Most lately, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions like a scavenger https://davids873fgr9.tkzblog.com/profile